Treatment
- Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK
M. Voysey, S. A. Costa Clemens, S. A. Madhi, The Lancet, Dec 8, 2020; DOI:10.1016/ S0140-6736(20)32661-1 - SARS-CoV-2 Vaccination — An Ounce (Actually, Much Less) of Prevention
Eric J. Rubin, M.D., Ph.D., and Dan L. Longo, M.D., NEJEM, Dec 14, 2020; DOI: 10.1056/NEJMe2034717 - Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK
M. Voysey, S. A. Costa Clemens, S. A. Madhi, The Lancet, Dec 8, 2020; DOI: 10.1016/S0140-6736(20)32661-1 - Neutralizing Antibodies against SARS-CoV-2 and Other Human Coronaviruses
Shibo Jiang, Christopher Hillyer, Lanying Du Trends in Immunology, May 2020, Vol. 41, No. 5; DOI: https://doi.org/10.1016/j.it.2020.03.007 - The Toughest Triage — Allocating Ventilators in a Pandemic
Robert D. Truog, Christine Mitchell, George Q. Daley NEJM 2020, March 23; DOI: 10.1056/NEJMp2005689 - Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial
Philippe Gautret et al. International Journal of Antimicrobial Agents 2020, March 20; doi: 10.1016/j.ijantimicag.2020.105949 - Learnings from Mayo Clinic’s Methods for Scaling a Coordinated and Comprehensive Plan for Covid-19
Namita Seth Mohta, Priya Sampathkumar NEJM CATALYST 2020, MARCH 19; Doi: 10.1056/CAT.20.0078 - A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19
Bin Cao et al. NEJM 2020, March 18; DOI: 10.1056/NEJMoa2001282 - COVID-19: consider cytokine storm syndromes and immunosuppression
Puja Mehta et al. The Lancet 2020, March 16; doi: 10.1016/S0140-6736(20)30628-0 - COVID-19 Illness in Native and Immunosuppressed States: A Clinical-Therapeutic Staging Proposal
Hasan K. Siddiqi, Mandeep R. Mehra JHLT 2020, March 20; doi: 10.1016/j.healun.2020.03.012 - Discovering drugs to treat coronavirus disease 2019 (COVID-19)
Liying Dong, Shasha Hu, Jianjun Gao Drug Discoveries & Therapeutics 2020, Feb 29; DOI: 10.5582/ddt.2020.01012
